DATEXIM

Datexim specializes in automated devices for digital cytology. Specifically, it produces the CytoProcessor, which processes cytological samples to enable digital analysis and microscopic examination. This device supports pathology workflows by streamlining the preparation and review of samples, aiding in diagnostic processes.

Datexim is headquartered in France. The company focuses on developing innovative solutions in digital cytology, leveraging artificial intelligence to enhance early cancer detection. Its primary product, the CytoProcessor, is designed to improve diagnostic accuracy and efficiency in pathology settings.

Datexim’s devices, including the CytoProcessor, are registered in the EUDAMED database. This platform is the official European Union registry for medical devices, ensuring transparency and traceability of authorized products within the EU market.

The CytoProcessor, Datexim’s primary device, falls under the classification of IVD General. This classification applies to in vitro diagnostic medical devices that do not pose significant risks and are used for general diagnostic purposes, such as cytology analysis.